Back Cover: Lactobacillus casei Alleviated the Abnormal Increase of Cholestasis‐Related Liver Indices During Tuberculosis Treatment: A Post Hoc Analysis of Randomized Controlled Trial. Issue 16 (18th August 2021)

• Record Type: Journal Article
• Authors: Xiong, Ke; Cai, Jing; Liu, Peiying; Wang, Jinyu; Zhao, Shanliang; Xu, Lei; Yang, Yang; Liu, Jiahong; Ma, Aiguo
• Is Part Of: Molecular nutrition & food research. Volume 65:Issue 16(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-08-18
• Subjects: Food -- Biotechnology -- Periodicals; Food -- Microbiology -- Periodicals; Nutrition -- Periodicals; Food -- Toxicology -- Periodicals; Nutrition -- Periodicals; Food Microbiology -- Periodicals; Food Technology -- Periodicals; Molecular Biology -- Periodicals; 664.0705
• DOI: 10.1002/mnfr.202170043
• Languages: English
• ISSNs: 1613-4125

Abstract

Abstract : Mol. Nutr. Food Res . 2021, 65, 202100108 DOI: 10.1002/mnfr.202100108 Lactobacillus casei supplementation is beneficial for suppressing abnormally elevated cholestasis‐related liver indices during tuberculosis treatment, which may be related to its effects on modifying gut microbiota, improving intestinal barrier function and reducing blood lipopolysaccharides. This is reported by Aiguo Ma and co‐workes in article number 2100108 .